perindopril/ amlodipine actavis tablett
teva b.v. - perindopriil+amlodipiin - tablett - 10mg+5mg 30tk; 10mg+5mg 90tk
perindopril/ amlodipine actavis tablett
teva b.v. - perindopriil+amlodipiin - tablett - 5mg+5mg 30tk; 5mg+5mg 10tk
perindopril/ amlodipine actavis tablett
teva b.v. - perindopriil+amlodipiin - tablett - 10mg+10mg 30tk
ranolazine stada toimeainet prolongeeritult vabastav tablett
stada arzneimittel ag - ranolasiin - toimeainet prolongeeritult vabastav tablett - 500mg 60tk; 500mg 30tk; 500mg 100tk
ranolazine stada toimeainet prolongeeritult vabastav tablett
stada arzneimittel ag - ranolasiin - toimeainet prolongeeritult vabastav tablett - 750mg 100tk; 750mg 60tk
ranolazine elc toimeainet prolongeeritult vabastav tablett
elc group s.r.o. - ranolasiin - toimeainet prolongeeritult vabastav tablett - 375mg 100tk; 375mg 30tk
ranolazine stada toimeainet prolongeeritult vabastav tablett
stada arzneimittel ag - ranolasiin - toimeainet prolongeeritult vabastav tablett - 375mg 60tk; 375mg 100tk
ranolazine elc toimeainet prolongeeritult vabastav tablett
elc group s.r.o. - ranolasiin - toimeainet prolongeeritult vabastav tablett - 750mg 100tk; 750mg 30tk
ranolazine elc toimeainet prolongeeritult vabastav tablett
elc group s.r.o. - ranolasiin - toimeainet prolongeeritult vabastav tablett - 500mg 30tk
zokinvy
eigerbio europe limited - lonafarnib - progeria; laminopathies - muud alimentary seedetrakti ja ainevahetust tooted, - zokinvy is indicated for the treatment of patients 12 months of age and older with a genetically confirmed diagnosis of hutchinson-gilford progeria syndrome or a processing-deficient progeroid laminopathy associated with either a heterozygous lmna mutation with progerin-like protein accumulation or a homozygous or compound heterozygous zmpste24 mutation.